Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-2-(TERT-BUTOXYCARBONYLAMINO-METHYL)-3-(1H-INDOL-3-YL)-PROPIONIC ACID is a chemical compound categorized under the class of propionic acids. It is a derivative of 1H-indol-3-yl and features a tert-butoxycarbonylamino-methyl group. (S)-2-(TERT-BUTOXYCARBONYLAMINO-METHYL)-3-(1H-INDOL-3-YL)-PROPIONIC ACID is known for its structural features and pharmacological properties, which make it a valuable asset in the pharmaceutical and organic chemistry sectors.

1050443-69-0

Post Buying Request

1050443-69-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (S)-2-(TERT-BUTOXYCARBONYLAMINO-METHYL)-3-(1H-INDOL-3-YL)-PROPIONIC ACID

    Cas No: 1050443-69-0

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • (2R)-3-([(TERT-BUTOXY)CARBONYL]AMINO)-2-(1H-INDOL-3-YLMETHYL)PROPANOIC ACID

    Cas No: 1050443-69-0

  • No Data

  • No Data

  • No Data

  • coolpharm Ltd
  • Contact Supplier

1050443-69-0 Usage

Uses

Used in Pharmaceutical Industry:
(S)-2-(TERT-BUTOXYCARBONYLAMINO-METHYL)-3-(1H-INDOL-3-YL)-PROPIONIC ACID is used as a building block for the synthesis of various biologically active molecules. Its unique structure and properties contribute to its potential applications in drug development and research, making it a promising candidate for creating new therapeutic agents.
Used in Organic Chemistry:
In the field of organic chemistry, (S)-2-(TERT-BUTOXYCARBONYLAMINO-METHYL)-3-(1H-INDOL-3-YL)-PROPIONIC ACID serves as an essential component in the creation of complex molecular structures. The tert-butoxycarbonylamino-methyl group not only provides stability and protection for the compound during chemical reactions but also aids in the synthesis process, enhancing the overall efficiency and effectiveness of the reactions involved.
The provided materials highlight the compound's significance in both the pharmaceutical and organic chemistry industries, emphasizing its role as a building block for the synthesis of biologically active molecules and its utility in drug development and research.

Check Digit Verification of cas no

The CAS Registry Mumber 1050443-69-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,0,4,4 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1050443-69:
(9*1)+(8*0)+(7*5)+(6*0)+(5*4)+(4*4)+(3*3)+(2*6)+(1*9)=110
110 % 10 = 0
So 1050443-69-0 is a valid CAS Registry Number.

1050443-69-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-(1H-indol-3-ylmethyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1050443-69-0 SDS

1050443-69-0Downstream Products

1050443-69-0Relevant articles and documents

Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1

Asgatay, Saa?dia,Champion, Christine,Marloie, Ga?l,Drujon, Thierry,Senamaud-Beaufort, Catherine,Ceccaldi, Alexandre,Erdmann, Alexandre,Rajavelu, Arumugam,Schambel, Philippe,Jeltsch, Albert,Lequin, Olivier,Karoyan, Philippe,Arimondo, Paola B.,Guianvarc'H, Dominique

, p. 421 - 434 (2014/02/14)

DNA methyltransferases (DNMT) are promising drug targets in cancer provided that new, more specific, and chemically stable inhibitors are discovered. Among the non-nucleoside DNMT inhibitors, N-phthaloyl-l-tryptophan 1 (RG108) was first identified as inhibitor of DNMT1. Here, 1 analogues were synthesized to understand its interaction with DNMT. The indole, carboxylate, and phthalimide moieties were modified. Homologated and conformationally constrained analogues were prepared. The latter were synthesized from prolinohomotryptophan derivatives through a methodology based amino-zinc-ene-enolate cyclization. All compounds were tested for their ability to inhibit DNMT1 in vitro. Among them, constrained compounds 16-18 and NPys derivatives 10-11 were found to be at least 10-fold more potent than the reference compound. The cytotoxicity on the tumor DU145 cell line of the most potent inhibitors was correlated to their inhibitory potency. Finally, docking studies were conducted in order to understand their binding mode. This study provides insights for the design of the next-generation of DNMT inhibitors.

Aminomethylation of chiral silyl enol ethers: access to β2-homotryptophane and β2-homolysine derivatives

Moumné, Roba,Larregola, Maud,Boutadla, Youcef,Lavielle, Solange,Karoyan, Philippe

, p. 4704 - 4707 (2008/09/21)

We describe here the aminomethylation of chiral silyl enol ether derivatives using iminium ion. The choice of judicious precursors with adequate protecting groups for the silylation/aminomethylation step was required to achieve the synthesis of β2-homotryptophane in few steps. The same methodology was used to prepare a β2-homolysine derivative.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1050443-69-0